✦ LIBER ✦

Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents

✍ Scribed by Frantz Foissac; Stéphane Blanche; Catherine Dollfus; Déborah Hirt; Ghislaine Firtion; Corinne Laurent; Jean-Marc Treluyer; Saïk Urien

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of tenofovir, nevirapine and e

✍ Eric Dailly; Olivier Tribut; Pierre Tattevin; Cédric Arvieux; Philippe Perré; Fr 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 90 KB

Population pharmacokinetics of lopinavir

✍ K. M. L. Crommentuyn; B. S. Kappelhoff; J. W. Mulder; A. T. A. Mairuhu; E. C. M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Population pharmacokinetics of indinavir

✍ Bregt S. Kappelhoff; Alwin D. R. Huitema; Sanjay U. C. Sankatsing; Pieter L. Mee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

A Low Dose of Ritonavir-Boosted Atazanav

✍ Avihingsanon, A; van der Lugt, J; Kerr, SJ; Gorowara, M; Chanmano, S; Ohata, P; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 759 KB

Tenofovir comedication does not impair t

✍ Nils von Hentig; Brenda Dauer; Annette Haberl; Stefan Klauke; Thomas Lutz; Schlo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 149 KB

Pharmacokinetics and Safety of Saquinavi

✍ Singh, K; Dickinson, L; Chaikan, A; Back, D; Fletcher, C; Pozniak, A; Moyle, G; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB